The Quigley (MM) (NASDAQ:QGLY)
Historical Stock Chart
From Jul 2019 to Jul 2024
DOYLESTOWN, Pa., June 18 /PRNewswire-FirstCall/ -- The Quigley Corporation, (NASDAQ:QGLY), http://www.quigleyco.com/, today announced that Ted Karkus, Chairman of the Board of The Quigley Corporation, has been appointed Interim Chief Executive Officer by the Board of Directors of the Company. Mr. Karkus will serve in this role effective June 18, 2009 and will be compensated at a rate of $5,000 per week for his services.
Mr. Karkus will temporarily assume the duties and responsibilities of Interim Chief Executive Officer while the Board of Directors reviews the Company's operations and staffing at the executive management level.
This appointment may be terminated by the Board of Directors at any time.
About The Quigley Corporation
The Quigley Corporation (NASDAQ:QGLYNASDAQ:http://www.Quigleyco.com) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufacturer of the COLD-EEZE(R) family of lozenges, gums and sugar free tablets clinically proven to cut the common cold nearly in half. COLD-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. The Quigley Corporation has several wholly owned subsidiaries; Quigley Manufacturing Inc. consists of two FDA approved facilities to manufacture COLD-EEZE(R) lozenges as well as fulfill other contract manufacturing opportunities. Quigley Pharma Inc. (http://www.quigleypharma.com/) conducts research in order to develop and commercialize a pipeline of patented botanical and naturally derived potential prescription drugs.
Forward-Looking Statements
Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risk, uncertainties and other factors that may cause the Company's actual performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statement. Factors that impact such forward-looking statements include, among others, changes in worldwide general economic conditions, changes in interest rates, government regulations, and worldwide competition.
CONTACT:
Ted Karkus Media Investor Relations
Chairman of the Board, CEO Karen Pineman Carl Hymans
The Quigley Corporation G.S. Schwartz & Co. G.S. Schwartz & Co.
(516) 569-9999 212.725.4500 212.725.4500
DATASOURCE: The Quigley Corporation
CONTACT: Ted Karkus, Chairman of the Board, CEO, The Quigley
Corporation, +1-516-569-9999; Media, Karen Pineman, G.S. Schwartz & Co.,
+1-212-725-4500, , or Investor Relations, Carl Hymans,
G.S. Schwartz & Co., +1-212-725-4500,
Web Site: http://www.quigleyco.com/